Cargando…

Exon 3 mutations of CTNNB1 drive tumorigenesis: a review

The canonical Wnt/β-catenin signaling pathway, an important modulator of progenitor cell proliferation and differentiation, is highly regulated for the maintenance of critical biological homeostasis. Decades of studies in cancer genetics and genomics have demonstrated that multiple genes encoding ke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Chao, Wang, Yingmei, Broaddus, Russell, Sun, Longhao, Xue, Fengxia, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797067/ https://www.ncbi.nlm.nih.gov/pubmed/29435196 http://dx.doi.org/10.18632/oncotarget.23695

Ejemplares similares

Nuclear β-Catenin Localization and Mutation of the CTNNB1 Gene: A Context-Dependent Association
por: Kim, Grace, et al.
Publicado: (2018)

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
por: Kurnit, Katherine C., et al.
Publicado: (2017)

Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy
por: Wang, Yingmei, et al.
Publicado: (2009)

CTNNB1 Mutation in Aldosterone Producing Adenoma
por: Wang, Jian-Jhong, et al.
Publicado: (2017)

CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma
por: Apps, J. R., et al.
Publicado: (2020)

Recurrent CTNNB1 mutations in craniofacial osteomas
por: Baumhoer, Daniel, et al.
Publicado: (2021)

Analysis of the Clinicopathologic Characteristics of Lung Adenocarcinoma With CTNNB1 Mutation
por: Zhou, Chao, et al.
Publicado: (2020)

Activating mutations in CTNNB1 in aldosterone producing adenomas
por: Åkerström, Tobias, et al.
Publicado: (2016)

Transcriptomic Characterization of Hepatocellular Carcinoma with CTNNB1 Mutation
por: Ding, Xiao, et al.
Publicado: (2014)

Ovarian insufficiency and CTNNB1 mutations drive malignant transformation of endometrial hyperplasia with altered PTEN/PI3K activities
por: Terakawa, Jumpei, et al.
Publicado: (2019)

CTNNB1 in neurodevelopmental disorders
por: Zhuang, Wenting, et al.
Publicado: (2023)

Familial Exudative Vitreoretinopathy and Systemic Abnormalities in Patients With CTNNB1 Mutations
por: Huang, Li, et al.
Publicado: (2023)

Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2016)

Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
por: Gao, Chao, et al.
Publicado: (2021)

PIK3CA mutation in a case of CTNNB1-mutant sinonasal glomangiopericytoma
por: Hong, Christopher S., et al.
Publicado: (2022)

Characteristics of cultured desmoid cells with different CTNNB1 mutation status
por: Hamada, Shunsuke, et al.
Publicado: (2015)

The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
por: Wu, Vin-Cent, et al.
Publicado: (2017)

Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
por: He, Juan, et al.
Publicado: (2021)

Nutlin‐3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation
por: Hui, Wen, et al.
Publicado: (2018)

Prognostic significance of CTNNB1 mutation in hepatocellular carcinoma: a systematic review and meta-analysis
por: Lu, Genlin, et al.
Publicado: (2023)

The Role of CTNNB1 in Endometrial Cancer
por: Ledinek, Živa, et al.
Publicado: (2022)

CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1
por: Zhang, Lei, et al.
Publicado: (2020)

Identification and Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma
por: Alaña, Lide, et al.
Publicado: (2022)

PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations
por: Cani, Carolina M.G., et al.
Publicado: (2011)

Somatic mutations in CDH1 and CTNNB1 in primary carcinomas at 13 anatomic sites
por: Busch, Evan L., et al.
Publicado: (2017)

Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survival
por: Maharjan, Rajani, et al.
Publicado: (2018)

Liver cancer with concomitant TP53 and CTNNB1 mutations: a case report
por: Friemel, Juliane, et al.
Publicado: (2016)

Trichoblastic carcinosarcoma with panfollicular differentiation (panfollicular carcinosarcoma) and CTNNB1 (beta‐catenin) mutation
por: Giang, Jenny, et al.
Publicado: (2020)

CTNNB1 S37C mutation causing cells proliferation and migration coupled with molecular mechanisms in lung adenocarcinoma
por: Zhou, Chao, et al.
Publicado: (2021)

MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
por: Wang, Yingmei, et al.
Publicado: (2016)

Erratum to: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
por: Wang, Yingmei, et al.
Publicado: (2017)

Glomangiopericytoma of the Nasal Cavity with CTNNB1 p.S37C Mutation: A Case Report and Literature Review
por: Kono, Michihisa, et al.
Publicado: (2018)

Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis
por: Travaglino, Antonio, et al.
Publicado: (2022)

Case Report: Targeted Therapy for Metastatic Solid Pseudopapillary Neoplasm of the Pancreas With CTNNB1 and PTEN Mutations
por: Wang, Xinbo, et al.
Publicado: (2021)

FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
por: Byron, Sara A., et al.
Publicado: (2012)

Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients
por: Lin, Selena Y., et al.
Publicado: (2021)

An Integrative Analysis Reveals the Underlying Association Between CTNNB1 Mutation and Immunotherapy in Hepatocellular Carcinoma
por: Mo, Zhuomao, et al.
Publicado: (2020)

Correction: FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
por: Byron, Sara A., et al.
Publicado: (2012)

BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma
por: Larkin, Sarah Jane, et al.
Publicado: (2014)

Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression
por: Liu, Tao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sjqmik7ob71n1ucaqdjvbbm323